BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24390739)

  • 1. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base.
    Colbert LE; Hall WA; Nickleach D; Switchenko J; Kooby DA; Liu Y; Gillespie T; Lipscomb J; Kauh J; Landry JC
    Cancer; 2014 Feb; 120(4):499-506. PubMed ID: 24390739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base.
    Kooby DA; Gillespie TW; Liu Y; Byrd-Sellers J; Landry J; Bian J; Lipscomb J
    Ann Surg Oncol; 2013 Oct; 20(11):3634-42. PubMed ID: 23771249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma.
    Hall WA; Colbert LE; Liu Y; Gillespie T; Lipscomb J; Hardy C; Kooby DA; Prabhu RS; Kauh J; Landry JC
    Cancer; 2013 Jun; 119(12):2350-7. PubMed ID: 23625519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreatic Adenocarcinoma Treated With Multiagent Neoadjuvant Chemotherapy in the Modern Era.
    Hue JJ; Dorth J; Sugumar K; Hardacre JM; Ammori JB; Rothermel LD; Saltzman J; Mohamed A; Selfridge JE; Bajor D; Winter JM; Ocuin LM
    Am Surg; 2021 Sep; 87(9):1386-1395. PubMed ID: 34382877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
    Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
    Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients.
    Mattiucci GC; Falconi M; VAN Stiphout RG; Alfieri S; Calvo FA; Herman JM; Maidment BW; Miller RC; Regine WF; Reni M; Sharma N; Partelli S; Genovesi D; Balducci M; Deodato F; Valentini V; Morganti AG
    Anticancer Res; 2015 Jun; 35(6):3441-6. PubMed ID: 26026108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
    Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
    Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes.
    Calvo FA; Sole CV; Atahualpa F; Lozano MA; Gomez-Espi M; Calin A; García-Alfonso P; Gonzalez-Bayon L; Herranz R; García-Sabrido JL
    Pancreatology; 2013; 13(6):576-82. PubMed ID: 24280572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
    Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L
    Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.
    Mellon EA; Springett GM; Hoffe SE; Hodul P; Malafa MP; Meredith KL; Fulp WJ; Zhao X; Shridhar R
    Cancer; 2014 Apr; 120(8):1171-7. PubMed ID: 24390779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.
    White RR; Hurwitz HI; Morse MA; Lee C; Anscher MS; Paulson EK; Gottfried MR; Baillie J; Branch MS; Jowell PS; McGrath KM; Clary BM; Pappas TN; Tyler DS
    Ann Surg Oncol; 2001 Dec; 8(10):758-65. PubMed ID: 11776488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.
    Murphy JE; Wo JY; Ryan DP; Jiang W; Yeap BY; Drapek LC; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Faris JE; Zhu AX; Goyal L; Lillemoe KD; DeLaney TF; Fernández-Del Castillo C; Ferrone CR; Hong TS
    JAMA Oncol; 2018 Jul; 4(7):963-969. PubMed ID: 29800971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
    Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
    Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
    Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
    Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.